Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GEO accession GSE240048 is currently private and is scheduled to be released on Jul 31, 2025.

ABSTRACT: GEO accession GSE240048 is currently private and is scheduled to be released on Jul 31, 2025.

PROVIDER: PRJNA1001981 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25511212_1.fastq.gz	Fastqsanger.gz
	SRR25511212_2.fastq.gz	Fastqsanger.gz
	SRR25511213_1.fastq.gz	Fastqsanger.gz
	SRR25511213_2.fastq.gz	Fastqsanger.gz
	SRR25511214_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 64

Similar Datasets

Examination of mouse tumor infiltrating immune cell expression changes after Maoa gene knock out

Project description:Examination of mouse tumor infiltrating immune cell expression changes after Maoa gene knock out

2021-02-09 | GSE153615 | GEO

Characterization of immune cells infiltrating islets using scRNA-seq

Project description:Characterization of immune cells infiltrating islets using scRNA-seq

| PRJNA655358 | ENA

Characterization of immune cells infiltrating pancreatic islets using scRNA-seq

Project description:Characterization of immune cells infiltrating pancreatic islets using scRNA-seq

| PRJNA516430 | ENA

Tumor-infiltrating immune cells of young and aged mice

Project description:Tumor-infiltrating immune cells of young and aged mice

| PRJNA495509 | ENA

Examination of mouse tumor infiltrating immune cell expression changes after Maoa gene knock out

Project description:Examination of mouse tumor infiltrating immune cell expression changes after Maoa gene knock out

| PRJNA643488 | ENA

scRNA-seq analysis of tumor infiltrating lymphocytes in PTENα-expressing tumors

Project description:scRNA-seq analysis of tumor infiltrating lymphocytes in PTENα-expressing tumors

| PRJNA738151 | ENA

scRNA-seq analysis of mouse tumor-infiltrating immune cells

Project description:Cancer immuno-surveillance and response to checkpoint blockade therapy can be affected by multiple environmental factors, including nutrition. However, the direct effects of individual nutrients on anti-tumoral immune responses remain poorly understood. Here we addressed the impact of dietary ligands of Aryl Hydrocarbon receptor (AhR), a transcription factor activated by indoles and tryptophan catabolites generated through food digestion and microbiota metabolism. To this aim, we analyzed pre-clinical tumor models in mice fed on a diet naturally poor in AhR ligands, or the same diet enriched for Indole-3-carbinol, a phytonutrient cleaved by stomach enzymes into AhR agonists.

2025-09-30 | GSE240048 | GEO

Single cell gene expression analysis of mouse melanoma tumor infiltrating leukocytes

Project description:The tumor immune cell composition dictates cancer outcomes. To capture this tumor immune cell diversity, we isolated tumor infiltrating leukocytes from tamoxifen induced tumors of Tyr::CreER;BRAFCAPTENloxp mice for single cell RNA sequencing

2021-04-15 | GSE149615 | GEO

Transcriptomic analysis of tumor-infiltrating dendritic cells in mouse subcutaneous tumor models

Project description:Transcriptomic analysis of tumor-infiltrating dendritic cells in mouse subcutaneous tumor models

| PRJNA435413 | ENA

scRNA-seq comparison of B16-GP33 tumor-infiltrating immune cells from IgG, anti-PD-1, anti-PSGL-1, or combination anti-PD-1 and anti-PSGL-1 treated mice

Project description:We use scRNA-seq to show the differences in tumor-infiltrating immune cells among IgG, anti-PD-1, anti-PSGL-1, and combination anti-PD-1 and anti-PSGL-1 treated mice. We show that anti-PSGL-1 treatment resulted in an increase in neutrophil and T cells, anti-PD-1 treatment resulted in an increase in macrophages, and the combination resulted in an increase in T cells and macrophages when compared to the tumors of IgG treated mice. Additionally, we show that Tregulatory cells are decreased in the tumors of anti-PSGL-1 and combination treated mice. Further, we find that anti-PSGL-1 treated CD8 T cells show upregulation of activation and survival genes, while combination treatment increased effector gene expression in CD8 T cells. Both anti-PSGL-1 treatment and combination treatment increase effector gene expression in CD4 T cells when compared to IgG. This scRNA-seq study shows the impact of IgG, anti-PD-1, anti-PSGL-1, and combination anti-PSGL-1 and anti-PD-1 antibody tteatment on tumor-infiltrating immune cells in B16-GP33 melnoma tumor bearing mice.

2022-02-07 | GSE196112 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data